Fired US Attorney Bharara was investigating Tom Price when he was let go.

quote:

---

Price fell under suspicion after it was learned that he purchased stock in a medical device company days before he introduced legislation that would benefit them.

---

quote:

---

you may have noticed some serious allegations of unethical stock trading from Democrats and a few pieces of misleading journalism. Most recently, there’s CNN’s allegation that Tom Price introduced the HIP Act (which would remove CMS regulations on medical device manufacturers) to boost the stock price of Zimmer Biomet after $2,697.74 of such stock was unknowingly purchased a week prior by Price’s Morgan Stanley financial adviser as part of his portfolio’s annual rebalance (a rebalance which included transacting in 69 other stocks on the same day as these reports will fail to mention).

These reports also fail to mention that Dr. Price began this legislative effort to delay these same CMS regulations back in 2015 and that HIP Act of 2016 had essentially zero chance of becoming law given the Obama administration’s public opposition. Not to mention, Zimmer Bionet stock actually fell both on the day of the introduction of the HIP Act, and the day after.

After having done some research on Rep. Price’s entire portfolio over the past 10 years and having spoken to those with detailed information on the matter, let me explain in detail how these allegations are completely unfounded.

LINK

---